STK11/LKB1 mutation in non-small cell lung cancer: Prognostic or predictive?

被引:0
|
作者
Rosellini, P. [1 ]
Girodet, P. O. [1 ]
机构
[1] Univ Bordeaux, CHU Bordeaux, CIC1401, Bordeaux, France
关键词
immunotherapy; KRAS; NSCLC; overall survival; STK11; TTF;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PM1-005
引用
收藏
页码:50 / 51
页数:2
相关论文
共 50 条
  • [1] Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
    Sumbly, Vikram
    Landry, Ian
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [2] STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?
    Di Federico, Alessandro
    De Giglio, Andrea
    Parisi, Claudia
    Gelsomino, Francesco
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 157 : 108 - 113
  • [3] LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value
    Facchinetti, Francesco
    Bluthgen, Maria Virginia
    Tergemina-Clain, Gabrielle
    Faivre, Laura
    Pignon, Jean-Pierre
    Planchard, David
    Remon, Jordi
    Soria, Jean-Charles
    Lacroix, Ludovic
    Besse, Benjamin
    [J]. LUNG CANCER, 2017, 112 : 62 - 68
  • [4] The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
    Mograbi, Baharia
    Heeke, Simon
    Hofman, Paul
    [J]. DIAGNOSTICS, 2021, 11 (02)
  • [5] Mutations of the LKB1/STK11 gene in non-small cell lung cancer with loss of heterozygosity
    Yang, Sei-Hoon
    Meerzaman, Daoud
    Mechanic, Leah E.
    Gill, Rajbir
    Dracheva, Tatiana
    Han, Seung-Bum
    Kim, Sam-Yong
    Bowman, Elise D.
    Harris, Curtis C.
    Jen, Jin
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 246 - 246
  • [6] Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer
    R K Gill
    S-H Yang
    D Meerzaman
    L E Mechanic
    E D Bowman
    H-S Jeon
    S Roy Chowdhuri
    A Shakoori
    T Dracheva
    K-M Hong
    J Fukuoka
    J-H Zhang
    C C Harris
    J Jen
    [J]. Oncogene, 2011, 30 : 3784 - 3791
  • [7] Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer
    Gill, R. K.
    Yang, S-H
    Meerzaman, D.
    Mechanic, L. E.
    Bowman, E. D.
    Jeon, H-S
    Chowdhuri, S. Roy
    Shakoori, A.
    Dracheva, T.
    Hong, K-M
    Fukuoka, J.
    Zhang, J-H
    Harris, C. C.
    Jen, J.
    [J]. ONCOGENE, 2011, 30 (35) : 3784 - 3791
  • [8] STK11/LKB1 revisited: A prognostic rather than predictive biomarker for immune checkpoint inhibitor in EGFR/ALKWT nonsquamous non-small cell lung cancer (NSCLC).
    Zhao, Hui
    Qi, Nan
    Chen, Dianjun
    Li, Donghui
    Fu, Yan
    Xu, Yu
    Wang, Guoqiang
    Bai, Yuezong
    Du, Nan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Cancer and LKB1/STK11 mutation spectrum in Peutz-Jeghers syndrome
    Mehenni, H
    Resta, N
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A568 - A568
  • [10] Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung
    Sanchez-Cespedes, M
    Parrella, P
    Esteller, M
    Nomoto, S
    Trink, B
    Engles, JM
    Westra, WH
    Herman, JG
    Sidransky, D
    [J]. CANCER RESEARCH, 2002, 62 (13) : 3659 - 3662